LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Uterine Serous Carcinoma Responds to the WEE1 Inhibitor Adavosertib.

Photo from wikipedia

The overall response rate to adavosertib was 29.4%; no biomarkers predicting response were found. Click to show full abstract

The overall response rate to adavosertib was 29.4%; no biomarkers predicting response were found.

Keywords: serous carcinoma; carcinoma responds; uterine serous; wee1 inhibitor; inhibitor adavosertib; responds wee1

Journal Title: Cancer discovery
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.